Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive B-Cell Lymphoma

被引：0
|
作者：
Li, Cong [1 ]
Lei, Tao [1 ]
Yu, Haifeng [1 ]
Chen, Xi [1 ]
Peng, Shuailing [1 ]
Han, Shuiyun [1 ]
Yang, Haiyan [1 ,2 ]
机构：
[1] Zhejiang Canc Hosp, Dept Lymphat Oncol, Hangzhou, Peoples R China
[2] Chinese Acad Sci, Hangzhou Inst Med HIM, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184694
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study
    Wu Yuchen
    Sun Xuefei
    Bai Xueyan
    Qian Jun
    Zhu Hong
    Cui Qu
    Xing Ruixian
    Chen Yuedan
    Liu Qing
    Lai Wenyuan
    Li Junhong
    Wang Yaming
    Sun Shengjun
    Ji Nan
    Liu Yuanbo
    中华神经外科杂志（英文）, 2021, 07 (02) : 143 - 150
  • [2] Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study
    Wu Y.
    Sun X.
    Bai X.
    Qian J.
    Zhu H.
    Cui Q.
    Xing R.
    Chen Y.
    Liu Q.
    Lai W.
    Li J.
    Wang Y.
    Sun S.
    Ji N.
    Liu Y.
    Chinese Neurosurgical Journal, 7 (1)
  • [3] Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma Who, What, and When?
    Schmitz, Norbert
    Nickelsen, Maike
    Savage, Kerry J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (06) : 1277 - +
  • [4] Rituximab-CHOP and Central Nervous System Prophylaxis Using Intrathecal Methotrexate in Primary Breast Diffuse Large B-Cell Lymphoma: A Prospective, Multicenter, Single-Arm Phase II Study
    Yhim, Ho-Young
    Suh, Cheolwon
    Kim, Seok Jin
    Yang, Deok-Hwan
    Eom, Hyeon-Seok
    Kim, Kyoung Ha
    Park, Yong
    Kim, Jin Seok
    Kim, Hyo Jung
    Yoon, Dok Hyun
    Kim, Won Seog
    Kwak, Jae-Yong
    BLOOD, 2019, 134
  • [5] CENTRAL NERVOUS SYSTEM RECURRENCE IN AGGRESSIVE B-CELL LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
    Chekan, A.
    Kichigina, M.
    Tumyan, G.
    Kovrigina, A.
    Tupitsin, N.
    Trofimova, O.
    Bykov, D.
    Poddubnaya, I.
    Osmanov, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 635 - 636
  • [6] Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma
    Nijland, Marcel
    Jansen, Anne
    Doorduijn, Jeanette K.
    Enting, Roelien H.
    Bromberg, Jacoline E. C.
    Kluin-Nelemans, Hanneke C.
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2074 - 2079
  • [7] Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System
    Hall, Kevin H.
    Valla, Kelly
    Flowers, Christopher R.
    Cohen, Jonathon B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (02): : 89 - 94
  • [8] Intrathecal Central Nervous System Prophylaxis in Patients with Diffuse Large B-Cell Lymphoma at an Academic Healthcare System
    Hall, Kevin H.
    Valla, Kelly
    Cohen, Jonathon B.
    Flowers, Christopher
    BLOOD, 2017, 130
  • [9] Intrathecal (IT) Chemotherapy for Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A Single Centre Retrospective Observational Study
    Attwell, Luke
    Gray, Benjamin
    Hall, Rachel
    Killick, Sally
    McCarthy, Helen
    Walewska, Renata
    Chacko, Joseph M.
    BLOOD, 2020, 136
  • [10] High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis
    Li, Yufeng
    Li, Yajun
    Zeng, Ruolan
    He, Yizi
    Liang, Liang
    Ou, Lijia
    Su, Chang
    Zhou, Hui
    Xiao, Ling
    JOURNAL OF CANCER, 2023, 14 (17): : 3182 - 3190
12345